In early March, the National Pharmaceutical Pricing Authority (NPPA), India's drug price regulator, fixed the ceiling prices of 463 brands of cancer medicines.

Indian pharma companies need to move fast on THE digital highway to stay relevant in the future.

The US-based insurance firm United Healthcare Services has filed a complaint against Dr Reddy's Laboratories and 42 other defendants.

The large cap stock fell 2.09% to 845 level in trade today compared to the previous close of 863 level on the BSE. The stock has lost 9.01% during the last one year.

Industry players expect more partnerships in the new year between public and the private sector in the healthcare space, which they feel is 'under-invested'

Ogivri (Trastuzumab), jointly developed by Biocon and Mylan, is the biosimilar version of Swiss drug maker Roche's Herceptin.

The US Food and Drug Administration is coming out with clear guidelines for clearing complex generics.

Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.

A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.